ArticleJournal of medicinal chemistry2020

Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor.

Kunal Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.